Clinical Trial Update: Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of a Tag-7 gene-modified vaccine in locally advanced or metastatic malignant melanoma or kidney canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Malignant Melanoma

Drugs mentioned

• Tag-7 gene-modified vaccine

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Melanoma, Kidney Cancer | Phase 1, Phase 2 | Status: COMPLETED